Related Experiment Video
Updated: Oct 13, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies
Andrea Gerbino1, Cinzia Forleo2, Serena Milano1
1Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
Insights
Mutations in the Lamin A/C gene (LMNA) trigger cardiac inflammation, evidenced by elevated granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6). This finding offers new diagnostic and therapeutic avenues for LMNA-related cardiomyopathies.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Immunology
Background:
- Mutations in the Lamin A/C gene (LMNA) are linked to cardiolaminopathies, causing heart dysfunction.
- The precise role of cardiac inflammation in LMNA mutation-related heart remodeling remains unclear.
Purpose of the Study:
- To investigate serum cytokine and chemokine profiles in patients with LMNA mutations.
- To correlate specific inflammatory markers with the severity of cardiac phenotypes.
Main Methods:
- Serum samples from 19 patients with pathogenic LMNA mutations and 11 healthy controls were analyzed.
- Cytokine/chemokine levels were profiled using multiplex assays.
- Expression of heat shock protein 70 (Hsp70) in serum exosomes was assessed.
Main Results:
- All patients with LMNA mutations exhibited elevated granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6).
- Increased levels of IL-1Ra, IL-1β, IL-4, IL-5, IL-8, and GM-CSF were observed in patients with more severe disease.
- Elevated Hsp70 expression in serum exosomes correlated with the most severe phenotypes.
Conclusions:
- Specific inflammatory profiles are associated with LMNA cardiomyopathies.
- Identifying these inflammatory signatures may provide novel diagnostic and prognostic tools.
- Targeting myocardial inflammation could be a therapeutic strategy for LMNA-related heart disease.
Abstract:
Mutations in Lamin A/C gene (lmna) cause a wide spectrum of cardiolaminopathies strictly associated with significant deterioration of the electrical and contractile function of the heart. Despite the continuous flow of biomedical evidence, linking cardiac inflammation to heart remodelling in patients harbouring lmna mutations is puzzling. Therefore, we profiled 30 serum cytokines/chemokines in patients belonging to four different families carrying pathogenic lmna mutations segregating with cardiac phenotypes at different stages of severity (n = 19) and in healthy subjects (n = 11). Regardless lmna mutation subtype, high levels of circulating granulocyte colony-stimulating factor (G-CSF) and interleukin 6 (IL-6) were found in all affected patients' sera. In addition, elevated levels of Interleukins (IL) IL-1Ra, IL-1β IL-4, IL-5 and IL-8 and the granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured in a large subset of patients associated with more aggressive clinical manifestations. Finally, the expression of the pro-inflammatory 70 kDa heat shock protein (Hsp70) was significantly increased in serum exosomes of patients harbouring the lmna mutation associated with the more severe phenotype. Overall, the identification of patient subsets with overactive or dysregulated myocardial inflammatory responses could represent an innovative diagnostic, prognostic and therapeutic tool against Lamin A/C cardiomyopathies.
Related Concept Videos
Myocarditis I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Rheumatic Heart Disease I: Introduction

